Bristol Myers Squibb vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb and Eli Lilly's financial performance was compared.

Bristol Myers Squibb recovered to $7.1B in net income while Eli Lilly more than doubled profits to $20.6B.

This news is primarily of interest to investors and has no direct impact on seafarers.